A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursGerhardt Attard, Maja J.A. de Jonge, L. Pronk et al.|British Journal of Cancer|2007Cited by 71
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumoursEdwina N. Scott, Johann S. de Bono, Anne Thomas et al.|Cancer Chemotherapy and Pharmacology|2009Cited by 34